Drug Shortage Report for TIMOLOL MALEATE-EX

Last updated on 2022-06-23 History
Report ID 163223
Drug Identification Number 02242275
Brand name TIMOLOL MALEATE-EX
Common or Proper name TIMOLOL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TIMOLOL
Strength(s) 0.25%
Dosage form(s) SOLUTION (EXTENDED RELEASE)
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML EGEL
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-22
Estimated end date 2022-09-30
Actual end date
Shortage status Actual shortage
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-06-22 English Compare
v2 2022-06-22 French Compare
v3 2022-06-23 English Compare

Showing 1 to 3 of 3